Skip to content

    Crop Life Science Limited

    Ankleshwar (Gujarat) based manufacturer of agrochemicals — insecticides, fungicides, herbicides, bio-pesticides, bio-fertilizers and plant growth regulators — sold across India and exported to about a dozen countries.

    Chemicals
    Commodities

    Overview

    Price

    Market Cap

    ₹105 Cr

    Sector

    Chemicals

    Commodities

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY23FY24FY25FY26FY26
    LiabilitiesEquity Capital1217171717
    Reserves2955606367
    Borrowings2735445857
    Other Liabilities3473608167
    Total Liabilities102180182220208
    AssetsFixed Assets1639383028
    CWIP00000
    Investments00133
    Other Assets86141143187177
    Total Assets102180182220208

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY23FY24FY25FY26
    ActivitiesCash from Operating2-8-2-8
    Cash from Investing-4-3-42
    Cash from Financing113422
    SummaryCapital Expenditure
    Free Cash Flow-3-13-6-4
    FCF Margin

    Valuation

    Assumptions

    Current — CLSL
    Price
    ₹44
    EPS (TTM)
    ₹7.32
    PE (TTM)
    6.0
    Profit growth

    The Earnings Per Share over the last 12 months.

    %

    Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).

    Pre-filled with the lower of median (6.6×) and current (6.0×) PE — the conservative anchor.

    %

    The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.

    Valuation

    Current price
    ₹44
    vs
    Fair value · 15% return
    ₹30
    31%Overvalued

    At 10% growth and a 6× exit, ₹44 only delivers your return if you pay ₹30. The price is currently baking in 18% growth.

    EPS grows 10%/yr for 5 years, then fades to 6% over 2, exits at 6×.

    YearGrowthEPS (₹)
    FY2710.0%8.05
    FY2810.0%8.86
    FY2910.0%9.74
    FY3010.0%10.72
    FY3110.0%11.79
    FY328.0% ·fade12.73
    FY336.0% ·fade13.50

    Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.

    Learn to analyse Crop Life Science Limited

    Guides on how to read this kind of business and the numbers that matter.